Medicine and Dentistry
Patient
100%
Sepsis
46%
Anti-biotics
39%
Diagnosis
34%
Randomized Controlled Trial
32%
Infection
32%
Diagnostic Accuracy
32%
Evaluation Study
29%
Pneumonia
27%
Antibiotic Therapy
24%
Adult
23%
Pathogen
22%
Therapeutic Procedure
22%
Systematic Review
21%
Culture
20%
Candidemia
19%
Specimen
18%
Inpatient
17%
Blood
17%
Assay
16%
Real Time Polymerase Chain Reaction
16%
Biological Marker
16%
Blood Culture
16%
Sensitivity and Specificity
14%
Analysis
14%
Organism
13%
Hospital
13%
Accuracy
12%
Cost-Effectiveness Analysis
12%
Polymerase Chain Reaction
12%
Bloodstream Infection
10%
Tea Tree Oil
10%
Glucan
10%
Methicillin Resistant Staphylococcus Aureus
10%
Antiinfective Agent
9%
Intensive Care
9%
Intensive Care Unit
9%
Base
9%
Bacterium
9%
Association
9%
Health
9%
Serum
8%
Health Care Cost
8%
Clinical Trial
8%
Combination Therapy
8%
Development
8%
Arm
7%
Meta-Analysis
7%
Diagnostic Test
7%
Oil Body
6%
Pharmacology, Toxicology and Pharmaceutical Science
Candida Albicans
28%
Antibiotics
26%
Candidemia
22%
Pneumonia
22%
Candida
20%
Ventilator Associated Pneumonia
17%
Infection
16%
Bloodstream Infection
16%
Antiinfective Agent
11%
Organisms
11%
Sepsis
10%
Aspergillosis
10%
Fluconazole
10%
Antibiotic Agent
10%
Biological Marker
10%
Infectious Agent
9%
Antifungal
8%
Antifungal Agent
8%
Candida Glabrata
8%
Complication
7%
Candida Dubliniensis
7%
Ciprofloxacin
7%
Clinical Trial
7%
Host
7%
Peptide
6%
Infection
6%
Gram Negative Bacterium
5%
Mycobacterium
5%
Mononucleosis
5%
Peptoid
5%
Heart Atrium Myxoma
5%
Antibiotic Therapy
5%
Peritonsillar Abscess
5%
Epidemiology
5%
Endocarditis
5%
Lung Infection
5%
Extended Spectrum Beta Lactamase Producing Escherichia Coli
5%
Quinolone
5%
Escherichia coli
5%
Cathelicidin Antimicrobial Peptide LL 37
5%
Quinoline Derived Antiinfective Agent
5%
Pathogenicity
5%
Mycoplasma
5%
Staphylococcus Aureus
5%
Corticosteroid
5%
Bacteremia
5%
Streptococcus equinus
5%
Antibiotic Resistance
5%
Biological Marker
5%
Randomized Controlled Trial
5%
Nursing and Health Professions
Diagnostic Accuracy
26%
Sepsis
24%
Evaluation Study
16%
Blood Culture
15%
Sensitivity and Specificity
14%
Intensive Care Unit
13%
Patient
13%
Bloodstream Infection
12%
Candidemia
11%
Diagnosis
11%
Standard
10%
Biological Marker
10%
Real Time Polymerase Chain Reaction
10%
Time
9%
Cost Effectiveness Analysis
8%
Assay
8%
Candidiasis
8%
Base
7%
Hospital Admission
7%
Infection
7%
Hospitalization
7%
Quality Adjusted Life Year
7%
Meta Analysis
7%
Length
6%
Combination Therapy
6%
Isolation
6%
Economic Evaluation
6%
Data Base
6%
Economic Analysis
6%
Intensive Care
6%
Antimicrobial Stewardship
6%
Clinical Effectiveness
5%
Hospital
5%
Control
5%
Sample
5%
Cream
5%
Length of Stay
5%
Antibiotic Therapy
5%
Diseases
5%
Adult
5%
Catheter Removal
5%
Epidemiology
5%
Tea Tree Oil
5%
Catheter Infection
5%
Ventilator-Associated Pneumonia
5%
Health Service
5%
Diagnosis
5%
Antibiotic Therapy
5%
Sepsis
5%
